These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20298260)

  • 1. Direct reprogramming 101.
    Takahashi K
    Dev Growth Differ; 2010 Apr; 52(3):319-33. PubMed ID: 20298260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of pluripotency: from mouse to human.
    Zaehres H; Schöler HR
    Cell; 2007 Nov; 131(5):834-5. PubMed ID: 18045526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion.
    Hasegawa K; Zhang P; Wei Z; Pomeroy JE; Lu W; Pera MF
    Stem Cells; 2010 Aug; 28(8):1338-48. PubMed ID: 20572011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
    Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
    Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2--brief report.
    Ho PJ; Yen ML; Lin JD; Chen LS; Hu HI; Yeh CK; Peng CY; Lin CY; Yet SF; Yen BL
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1905-7. PubMed ID: 20689077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using small molecules to improve generation of induced pluripotent stem cells from somatic cells.
    Desponts C; Ding S
    Methods Mol Biol; 2010; 636():207-18. PubMed ID: 20336525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse induced pluripotent stem cells.
    Geoghegan E; Byrnes L
    Int J Dev Biol; 2008; 52(8):1015-22. PubMed ID: 18956334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Induced pluripotent stem cells generated from reprogramming differentiated cells by defined factors].
    Xia X; Chu J; Chen X
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1121-7. PubMed ID: 18837383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotency with endogenous and inducible genes.
    Duinsbergen D; Eriksson M; 't Hoen PA; Frisén J; Mikkers H
    Exp Cell Res; 2008 Oct; 314(17):3255-63. PubMed ID: 18656469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
    Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
    Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.
    Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA
    Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cells. A new year and a new era.
    Pera MF
    Nature; 2008 Jan; 451(7175):135-6. PubMed ID: 18185576
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.
    Meissner A; Wernig M; Jaenisch R
    Nat Biotechnol; 2007 Oct; 25(10):1177-81. PubMed ID: 17724450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin-Remodeling Components of the BAF Complex Facilitate Reprogramming.
    Singhal N; Graumann J; Wu G; Araúzo-Bravo MJ; Han DW; Greber B; Gentile L; Mann M; Schöler HR
    Cell; 2010 Jun; 141(6):943-55. PubMed ID: 20550931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells.
    Xu N; Papagiannakopoulos T; Pan G; Thomson JA; Kosik KS
    Cell; 2009 May; 137(4):647-58. PubMed ID: 19409607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells.
    Liu X; Huang J; Chen T; Wang Y; Xin S; Li J; Pei G; Kang J
    Cell Res; 2008 Dec; 18(12):1177-89. PubMed ID: 19030024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
    Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
    Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging methods for preparing iPS cells.
    Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
    Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.